Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Sep 12;175(6):611-7.
doi: 10.1503/cmaj.060236.

Natriuretic peptides in the diagnosis and management of heart failure

Affiliations
Review

Natriuretic peptides in the diagnosis and management of heart failure

G Michael Felker et al. CMAJ. .

Abstract

The natriuretic peptides are a family of related hormones that play a crucial role in cardiovascular homeostasis. They have recently emerged as potentially important clinical markers in heart failure. Recent data have suggested an important role for these markers in establishing the diagnosis of heart failure in patients with unexplained dyspnea in both acute care and ambulatory settings. Other clinical uses of the natriuretic peptides, such as screening for asymptomatic ventricular dysfunction, establishing prognosis or guiding titration of drug therapy, are under investigation but have not yet sufficiently been validated for widespread clinical use.

PubMed Disclaimer

Figures

Box 1
Box 1
None
Fig. 1: Receiver operating characteristic (ROC) curve for N-terminal B-type natriuretic peptide fragment (NT-proBNP) in the PRIDE study involving 600 patients presenting to the emergency department with acute dyspnea. Five possible decision thresholds are shown, ranging from 300 to 1000 pg/mL, with corresponding sensitivities and specificities. Reproduced, with permission, from Januzzi et al. © 2005 Elsevier. Additional data provided by Januzzi.
None
Fig. 2: Performance of acute congestive heart failure score in the diagnosis of heart failure in the derivation cohort from the PRIDE study (light bars) and the validation cohort from New Zealand (dark bars). Modified, with permission, from Baggish et al.
None
Fig. 3: Nomogram version of Bayes' Theorem. Starting with a patient in whom the diagnosis is uncertain after clinical evaluation (e.g., pretest probability of 50%), a likelihood ratio of 10 or greater for a positive test result is required to rule in disease with reasonable certainty (i.e., post-test probability of 90% or greater), whereas a likelihood ratio of 0.10 or smaller for a negative test result is required to rule out disease with reasonable certainty (i.e., post-test probability of 10% or lower). Adapted, with permission, from Fagan TJ. Nomogram for Bayes' formula. N Engl J Med 1975;293:257. Copyright © 1975 Massachusetts Medical Society. All rights reserved.

Comment in

  • Natriuretic peptides and heart failure.
    McLachlan CS, Yu H, Mossop P. McLachlan CS, et al. CMAJ. 2007 Feb 27;176(5):659. doi: 10.1503/cmaj.1060215. CMAJ. 2007. PMID: 17325337 Free PMC article. No abstract available.

References

    1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction — summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2002;40:1366-74. - PubMed
    1. Khera A, de Lemos JA, Peshock RM, et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006;113:38-43. - PubMed
    1. De Bold AJ, Borenstein HB, Veress AT, et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94. - PubMed
    1. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12. - PMC - PubMed
    1. Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464-9. - PubMed

MeSH terms